About IJPC
The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal emphasizing quality pharmaceutical compounding.
The Journal is available in both printed and electronic format with digital versions of individual articles and complete issues delivered in Adobe® Acrobat PDF format.
Search the Journal by issue, topic or keyword.
Request a free copy of the Journal
Material printed in IJPC is covered by copyright. All rights reserved. See the Reprints and Permissions Page for more information.
Request a copy of "Benzoate or Not to Benzoate: Cats Are the Question, To"
Read Abstract
A link to this sample article download page may be freely posted on web sites, chat rooms, and message boards provided that attribution to IJPC is included.
The URL for this item is http://ijpc.com/​Sample/​Article.cfm?SID=13
The sample document may NOT be electronically posted, published, or redistributed without the prior permission of IJPC.
Complete the following to have a download link emailed to you.
Related Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Benzoate or Not to Benzoate: Cats Are the Question, To
Davidson Gigi S
|
Mar/Apr 2001
Pg. 89-90
View Sample |
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
|
Nov/Dec 2008
Pg. 558-564
|
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 320
|
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
|
Mar/Apr 2001
Pg. 92-94
|
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate
Fan Bin, Stewart James T, White Catherine A
|
Mar/Apr 2001
Pg. 153-156
|
Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 46
|
Understanding Feline Hyperthyroidism
Davidson Gigi S
|
Sep/Oct 2003
Pg. 345-347
|
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
|
Nov/Dec 2006
Pg. 411-414
|
Psychotropic Medications in the Treatment of Feline Urine Spraying
Simpson Barbara Sherman, Vail Jane
|
Jan/Feb 2007
Pg. 44-48
|
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William, Helms Scott R
|
Sep/Oct 2008
Pg. 392-397
|
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara, Browne Paul
|
Nov/Dec 2010
Pg. 488-491
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
|
Nov/Dec 2022
Pg. 468-472
|
Case Studies of Compounded Tramadol Use in Cats
Ray Joel, Jordan Dinah, Pinelli Chris, Fackler Bethany, Boggess Donan, Clark Justin
|
Jan/Feb 2012
Pg. 44-49
|
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report
Muller George
|
May/Jun 2010
Pg. 215-217
|
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Meadows Richard L, Muller George
|
Sep/Oct 2010
Pg. 382-394
|
Drug Therapy for Acute and Chronic Pain in the Cat
Lascelles B Duncan
|
Sep/Oct 2002
Pg. 338-343
|
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
|
Jan/Feb 2021
Pg. 24-28
|
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension
Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J
|
Jul/Aug 2018
Pg. 326-328
|
Benzyl Benzoate Lotion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 261
|
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
|
Jan/Feb 2020
Pg. 77-82
|
Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
|
Nov/Dec 2017
Pg. 446-452
|
A Review of Stomatitis and Treatment in Cats
Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
|
Sep/Oct 2009
Pg. 372-381
|
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
|
Nov/Dec 2006
Pg. 418
|
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
|
Nov/Dec 2006
Pg. 434-435
|
Metronidazole 1% and Silver Sulfadiazine 1% Cream, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 230
|
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Mason Dave
|
Jan/Feb 1999
Pg. 34-35
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
Metronidazole in Normal Saline Enema
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 69
|
Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 425
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Stability of Metronidazole Suspensions
Donnelly Ronald F, Ying James
|
May/Jun 2015
Pg. 248-251
|
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 406
|
Metronidazole 50 mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 52
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021
Pg. 169-175
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
|
May/Jun 2022
Pg. 238
|
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 430
|
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 57
|
Caffeine and Sodium Benzoate 250-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2002
Pg. 449
|
Feline Urologic Syndrome and Diet Formulation
Long Scott F
|
Sep/Oct 1999
Pg. 366-367
|
Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism
Wingate Gary
|
Sep/Oct 2002
Pg. 344-345
|
Buspirone HCl 2.5-mg/0.1-mL in PLO for Cats
Allen Loyd V Jr
|
May/Jun 1999
Pg. 219
|
Ringworms in Cats
Franck Paul W, Allen Cheryl, Thomasson Alex
|
Jan/Feb 1999
Pg. 38
|
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
|
May/Jun 2017
Pg. 242-246
|
Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy
Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
|
May/Jun 2011
Pg. 214-217
|
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 157
|
Tetracycline 2.4% or Metronidazole 10% Periodontal Gel
Allen Loyd V Jr
|
Jan/Feb 1999
Pg. 51
|
Stability of Ceftriaxone Sodium When Mixed with Metronidazole Injection
Gupta Vishnu D, Maswoswe J
|
Jul/Aug 1997
Pg. 280-281
|
Metronidazole and Neomycin Sulfate Irrigation Solution
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 305
|
The Formulation Development and Stability of Metronidazole Suspension
Alexander Kenneth S, Vangala Shyam Sundar KS, Dollimore David
|
May/Jun 1997
Pg. 200-205
|
Metronidazole 15-mg/mL Suspension
Gupta Vishnu D, Maswoswe J, Bailey RE
|
May/Jun 1997
Pg. 202
|
Misoprostol 0.0024%, Metronidazole 2%, and Pentoxifyline 5% Decubitus Ulcer Cream
Allen Loyd V Jr
|
May/Jun 2002
Pg. 204
|
Metronidazole 1% Topical Spray
Allen Loyd V Jr
|
Mar/Apr 2002
Pg. 131
|
Metronidazole 2%, Misoprostol 0.0024% and Phenytoin 5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 299
|
Metronidazole 2% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 300
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Davidson Gigi S
|
May/Jun 2004
Pg. 169-172
|
Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 67
|
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
May/Jun 2014
Pg. 253-255
|
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R, Davidson Gigi S
|
Sep/Oct 2014
Pg. 366-369
|
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date
Pignato Alyssa, Pankaskie Marvin, Birnie Christine
|
Nov/Dec 2010
Pg. 522-525
|
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
|
Jul/Aug 2020
Pg. 327-336
|
Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 56
|
Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions
Kegele Carolina Schettino, Marianni Bruna, Polonini Hudson
|
Jan/Feb 2025
Pg. 64-76
|
Featured Excipient: Plasticizers
Allen Loyd V Jr
|
Mar/Apr 2003
Pg. 145-148
|
Including Pets in Diabetic Care
Davidson Gigi S
|
Mar/Apr 2007
Pg. 126-130
|
Calculations: Compounding for Veterinary Patients
Stockton Shelly J
|
Sep/Oct 2007
Pg. 412
|
Calculations: Compounding for Large and Small Animals
Stockton Shelly J
|
Nov/Dec 2006
Pg. 449
|
Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
|
Sep/Oct 2008
Pg. 398-401
|
Compounding for Cancer in Companion Animals
Mixon William, Northrup Nicole, Vail Jane
|
Jan/Feb 2009
Pg. 42-49
|
Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
|
Jul/Aug 2012
Pg. 276-286
|
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
|
Sep/Oct 2013
Pg. 424-431
|
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P, Muller George
|
May/Jun 2014
Pg. 190-200
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
Calculations
Prince Shelly J
|
Sep/Oct 2003
Pg. 372
|
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
|
Jul/Aug 2004
Pg. 265-267
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3
Davidson Gigi S
|
Sep/Oct 2004
Pg. 359-367
|
Call of the Wild: Compounding for Zoos and Exotics
Hudson Sonora
|
May/Jun 1999
Pg. 176-179
|
Compounding for Creatures: What Works
Davis Jeanie Lerche
|
May/Jun 1999
Pg. 182-185
|
Options in Wound Care
Kincaid Michele R
|
Mar/Apr 2002
Pg. 92-95
|
The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
|
Mar/Apr 2001
Pg. 86-88
|
Providing Positive Outcomes through Compounding for Animal Cancer Patients
Davidson Gigi S
|
Jul/Aug 2000
Pg. 264-272
|
Veterinary Compounding: A Bird's Eye View
Jordan Dinah G
|
Jul/Aug 1997
Pg. 222-227
|
Suggested Flavors for Veterinary Medications
Allen Loyd V Jr
|
Jul/Aug 1997
Pg. 228
|
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
|
Nov/Dec 2022
Pg. 480-488
|
Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals
Semighini Flavia, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
|
Nov/Dec 2023
Pg. 454-460
|
Return to Top |
|